313 related articles for article (PubMed ID: 329686)
21. Different insulin-secretory responses to calcium-channel blockers in islets of lean and obese (ob/ob) mice.
Black MA; Fournier LA; Heick HM; Bégin-Heick N
Biochem J; 1988 Jan; 249(2):401-7. PubMed ID: 2449178
[TBL] [Abstract][Full Text] [Related]
22. Defective early phase insulin release in perifused isolated pancreatic islets of spiny mice (Acomys cahirinus).
Rabinovitch A; Gutzeit A; Kikuchi M; Cerasi E; Renold AE
Diabetologia; 1975 Oct; 11(5):457-65. PubMed ID: 171800
[TBL] [Abstract][Full Text] [Related]
23. The influence of K(+)-induced membrane depolarization on insulin secretion in islets of lean and obese (ob/ob) mice.
Fournier LA; Heick HM; Bégin-Heick N
Biochem Cell Biol; 1990 Jan; 68(1):243-8. PubMed ID: 2190618
[TBL] [Abstract][Full Text] [Related]
24. Effects of cholinergic m-receptor agonists on insulin release in islets from obese and lean mice of different ages: the importance of bicarbonate.
Persson-Sjögren S; Lindström P
Pancreas; 2004 Nov; 29(4):e90-9. PubMed ID: 15502638
[TBL] [Abstract][Full Text] [Related]
25. Taurine supplementation ameliorates glucose homeostasis, prevents insulin and glucagon hypersecretion, and controls β, α, and δ-cell masses in genetic obese mice.
Santos-Silva JC; Ribeiro RA; Vettorazzi JF; Irles E; Rickli S; Borck PC; Porciuncula PM; Quesada I; Nadal A; Boschero AC; Carneiro EM
Amino Acids; 2015 Aug; 47(8):1533-48. PubMed ID: 25940922
[TBL] [Abstract][Full Text] [Related]
26. Effect of hyperglycaemia on muscarinic M3 receptor expression and secretory sensitivity to cholinergic receptor activation in islets.
Hauge-Evans AC; Reers C; Kerby A; Franklin Z; Amisten S; King AJ; Hassan Z; Vilches-Flores A; Tippu Z; Persaud SJ; Jones PM
Diabetes Obes Metab; 2014 Oct; 16(10):947-56. PubMed ID: 24720683
[TBL] [Abstract][Full Text] [Related]
27. Effects of somatostatin on the biosynthesis and release of insulin from isolated pancreatic islets.
Olsson SE; Anderson A; Petersson B; Hellerström C
Diabete Metab; 1976 Dec; 2(4):199-202. PubMed ID: 797594
[TBL] [Abstract][Full Text] [Related]
28. Glucagon and insulin secretion by islets of lean and obese (ob/ob) mice.
Dunbar JC; Walsh MF
Horm Metab Res; 1980 Jan; 12(1):39-40. PubMed ID: 6987139
[No Abstract] [Full Text] [Related]
29. Zinc supplementation attenuates insulin secretory activity in pancreatic islets of the ob/ob mouse.
Begin-Heick N; Dalpe-Scott M; Rowe J; Heick HM
Diabetes; 1985 Feb; 34(2):179-84. PubMed ID: 3881305
[TBL] [Abstract][Full Text] [Related]
30. Pancreatic islets of obese hyperglycemic mice (ob/ob).
Tomita T; Doull V; Pollock HG; Krizsan D
Pancreas; 1992; 7(3):367-75. PubMed ID: 1594559
[TBL] [Abstract][Full Text] [Related]
31. Abnormal regulation of insulin secretion in the genetically obese (ob/ob) mouse.
Black M; Heick HM; Bégin-Heick N
Biochem J; 1986 Sep; 238(3):863-9. PubMed ID: 3026362
[TBL] [Abstract][Full Text] [Related]
32. Effects of growth hormone-releasing hormone on the secretion of islet hormones and on glucose homeostasis in lean and genetically obese-diabetic (ob/ob) mice and normal rats.
Bailey CJ; Wilkes LC; Flatt PR; Conlon JM; Buchanan KD
J Endocrinol; 1989 Oct; 123(1):19-24. PubMed ID: 2572664
[TBL] [Abstract][Full Text] [Related]
33. Systemic treatment with sympatholytic dopamine agonists improves aberrant beta-cell hyperplasia and GLUT2, glucokinase, and insulin immunoreactive levels in ob/ob mice.
Jetton TL; Liang Y; Cincotta AH
Metabolism; 2001 Nov; 50(11):1377-84. PubMed ID: 11699060
[TBL] [Abstract][Full Text] [Related]
34. Oscillations in oxygen tension and insulin release of individual pancreatic ob/ob mouse islets.
Ortsäter H; Liss P; Lund PE; Akerman KE; Bergsten P
Diabetologia; 2000 Oct; 43(10):1313-8. PubMed ID: 11079751
[TBL] [Abstract][Full Text] [Related]
35. Leptin constrains acetylcholine-induced insulin secretion from pancreatic islets of ob/ob mice.
Chen NG; Swick AG; Romsos DR
J Clin Invest; 1997 Sep; 100(5):1174-9. PubMed ID: 9276734
[TBL] [Abstract][Full Text] [Related]
36. Effect of glucose stimulation on 45calcium uptake and total calcium content of pancreatic islets of fed and fasted rats and obese hyperglycemic mice.
Wolters GH; Wiegman JB; Konijnendijk W
Diabetes; 1983 Feb; 32(2):124-9. PubMed ID: 6337894
[TBL] [Abstract][Full Text] [Related]
37. Glucocorticoid increases glucose cycling and inhibits insulin release in pancreatic islets of ob/ob mice.
Khan A; Ostenson CG; Berggren PO; Efendic S
Am J Physiol; 1992 Oct; 263(4 Pt 1):E663-6. PubMed ID: 1384356
[TBL] [Abstract][Full Text] [Related]
38. Influence of the pituitary gland on insulin secretion in the genetically obese (ob/ob) mouse.
Beloff-Chain A; Edwardson JA; Hawthorn J
J Endocrinol; 1975 Apr; 65(1):109-16. PubMed ID: 167090
[TBL] [Abstract][Full Text] [Related]
39. Dual action of beta-endorphin on insulin release in genetically obese and lean mice.
Khawaja XZ; Green IC
Peptides; 1991; 12(2):227-33. PubMed ID: 2067974
[TBL] [Abstract][Full Text] [Related]
40. Increased responsiveness to the hyperglycemic, hyperglucagonemic and hyperinsulinemic effects of circulating norepinephrine in ob/ob mice.
Liang Y; Cincotta AH
Int J Obes Relat Metab Disord; 2001 May; 25(5):698-704. PubMed ID: 11360153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
